RR

Rajiv Raswant

Active Director Director DIN 09046439
DIN 09046439 First appointment Jan 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajiv Raswant

Data last updated:

Rajiv Raswant is a Director at Zygotecare Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals.

DIN 09046439
Primary Designation Director
Industry Chemicals
First Appointment 30 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20212021Active

Board colleagues of Rajiv Raswant

NameDINCompanyDesignation
Usha Raswant09046440Zygotecare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zygotecare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajiv Raswant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Raswant

Rajiv Raswant currently holds 1 directorship: Zygotecare Pharmaceuticals Private Limited (Director, since 30 Jan 2021).

Rajiv Raswant was first appointed on 30 Jan 2021 as Director at Zygotecare Pharmaceuticals Private Limited.

The current boards of Rajiv Raswant's companies include Usha Raswant (Zygotecare Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available